Price T Rowe Associates Inc Syndax Pharmaceuticals Inc Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 48,927 shares of SNDX stock, worth $727,055. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,927

Previous 48,198 1.51%

Holding current value

$727,055

Previous $990,000 4.85%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.93 - $24.81 $13,070 - $18,086	729 Added 1.51%	48,927 $942,000
Q2 2024 Aug 14, 2024	BUY	$18.82 - $23.79 $69,408 - $87,737	3,688 Added 8.29%	48,198 $990,000
Q1 2024 May 15, 2024	BUY	$19.71 - $24.57 $359,569 - $448,230	18,243 Added 69.45%	44,510 $1.06 Million
Q4 2023 Feb 14, 2024	BUY	$11.39 - $21.67 $21,151 - $40,241	1,857 Added 7.61%	26,267 $568,000
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $21,358 - $32,023	1,471 Added 6.41%	24,410 $355,000
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $223,976 - $258,238	11,575 Added 101.86%	22,939 $481,000
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $41,320 - $57,960	2,000 Added 21.36%	11,364 $241,000
Q4 2022 Feb 14, 2023	BUY	$20.64 - $26.24 $19,298 - $24,534	935 Added 11.09%	9,364 $238,000
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $156,020 - $208,954	8,429 New	8,429 $203,000
Q4 2021 Feb 14, 2022	SELL	$15.23 - $22.47 $7.86 Million - $11.6 Million	-516,098 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.87 - $19.8 $1.33 Million - $1.89 Million	95,678 Added 22.76%	516,098 $9.86 Million
Q2 2021 Aug 16, 2021	SELL	$13.42 - $25.18 $249,571 - $468,272	-18,597 Reduced 4.24%	420,420 $7.22 Million
Q1 2021 May 17, 2021	BUY	$19.28 - $24.59 $5.16 Million - $6.58 Million	267,578 Added 156.08%	439,017 $9.82 Million
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $2.59 Million - $4.53 Million	171,439 New	171,439 $3.81 Million

Others Institutions Holding SNDX

# of Institutions

232

Shares Held

93.8M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $841M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Syndax Pharmaceuticals Inc Transaction History